Invention Grant
US08173644B2 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
有权
3-取代 - [1,2,3] - 苯并三嗪酮化合物,用于增强谷氨酸能突触应答
- Patent Title: 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
- Patent Title (中): 3-取代 - [1,2,3] - 苯并三嗪酮化合物,用于增强谷氨酸能突触应答
-
Application No.: US12448784Application Date: 2007-12-28
-
Publication No.: US08173644B2Publication Date: 2012-05-08
- Inventor: Alexis Cordi , Gary Rogers , Rudolf Mueller
- Applicant: Alexis Cordi , Gary Rogers , Rudolf Mueller
- Applicant Address: FR Suresnes Cedex
- Assignee: Les Laboratoires Servier
- Current Assignee: Les Laboratoires Servier
- Current Assignee Address: FR Suresnes Cedex
- Agency: Hueschen and Sage
- International Application: PCT/US2007/026416 WO 20071228
- International Announcement: WO2008/085506 WO 20080717
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61K31/5365
![3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses](/abs-image/US/2012/05/08/US08173644B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for higher order behaviors. These brain networks are involved in cognitive abilities related to memory impairment, such as is observed in a variety of dementias, an in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia and affective disorders. In a particular aspect, the present invention relates to a compound useful for treatment of such conditions, and methods of using this compound for such treatment.
Public/Granted literature
- US20100137295A1 3-SUBSTITUTED-[1,2,3]-BENZOTRIAZINONE COMPOUND FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES Public/Granted day:2010-06-03
Information query